Negative regulation of inducible nitric-oxide synthase expression mediated through transforming growth factor-beta-dependent modulation of transcription factor TCF11
Inducible nitric-oxide synthase (iNOS) plays a central role in the regulation of vascular function and response to injury. A central mediator controlling iNOS expression is transforming growth factor-beta (TGF-beta), which represses its expression through a mechanism that is poorly understood. We ha...
Saved in:
| Published in: | The Journal of biological chemistry Vol. 282; no. 51; p. 36837 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
21.12.2007
|
| Subjects: | |
| ISSN: | 0021-9258 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Inducible nitric-oxide synthase (iNOS) plays a central role in the regulation of vascular function and response to injury. A central mediator controlling iNOS expression is transforming growth factor-beta (TGF-beta), which represses its expression through a mechanism that is poorly understood. We have identified a binding site in the iNOS promoter that interacts with the nuclear heterodimer TCF11/MafG using chromatin immunoprecipitation and mutation analyses. We demonstrate that binding at this site acts to repress the induction of iNOS gene expression by cytokines. We show that this repressor is induced by TGF-beta1 and by Smad6-short, which enhances TGF-beta signaling. In contrast, the up-regulation of TCF11/MafG binding could be suppressed by overexpression of the TGF-beta inhibitor Smad7, and a small interfering RNA to TCF11 blocked the suppression of iNOS by TGF-beta. The binding of TCF11/MafG to the iNOS promoter could be enhanced by phorbol 12-myristate 13-acetate and suppressed by the protein kinase C inhibitor staurosporine. Moreover, the induction of TCF11/MafG binding by TGF-beta and Smad6-short could be blocked by staurosporine, and the effect of TGF-beta was blocked by the selective protein kinase C inhibitor calphostin C. Consistent with the in vitro data, we found suppression of TCF11 coincident with iNOS up-regulation in a rat model of endotoxemia, and we observed a highly significant negative correlation between TCF11 and nitric oxide production. Furthermore, treatment with activated protein C, a serine protease effective in septic shock, blocked the down-regulation of TCF11 and suppressed endotoxin-induced iNOS. Overall, our results demonstrate a novel mechanism by which iNOS expression is regulated in the context of inflammatory activation. |
|---|---|
| AbstractList | Inducible nitric-oxide synthase (iNOS) plays a central role in the regulation of vascular function and response to injury. A central mediator controlling iNOS expression is transforming growth factor-beta (TGF-beta), which represses its expression through a mechanism that is poorly understood. We have identified a binding site in the iNOS promoter that interacts with the nuclear heterodimer TCF11/MafG using chromatin immunoprecipitation and mutation analyses. We demonstrate that binding at this site acts to repress the induction of iNOS gene expression by cytokines. We show that this repressor is induced by TGF-beta1 and by Smad6-short, which enhances TGF-beta signaling. In contrast, the up-regulation of TCF11/MafG binding could be suppressed by overexpression of the TGF-beta inhibitor Smad7, and a small interfering RNA to TCF11 blocked the suppression of iNOS by TGF-beta. The binding of TCF11/MafG to the iNOS promoter could be enhanced by phorbol 12-myristate 13-acetate and suppressed by the protein kinase C inhibitor staurosporine. Moreover, the induction of TCF11/MafG binding by TGF-beta and Smad6-short could be blocked by staurosporine, and the effect of TGF-beta was blocked by the selective protein kinase C inhibitor calphostin C. Consistent with the in vitro data, we found suppression of TCF11 coincident with iNOS up-regulation in a rat model of endotoxemia, and we observed a highly significant negative correlation between TCF11 and nitric oxide production. Furthermore, treatment with activated protein C, a serine protease effective in septic shock, blocked the down-regulation of TCF11 and suppressed endotoxin-induced iNOS. Overall, our results demonstrate a novel mechanism by which iNOS expression is regulated in the context of inflammatory activation. Inducible nitric-oxide synthase (iNOS) plays a central role in the regulation of vascular function and response to injury. A central mediator controlling iNOS expression is transforming growth factor-beta (TGF-beta), which represses its expression through a mechanism that is poorly understood. We have identified a binding site in the iNOS promoter that interacts with the nuclear heterodimer TCF11/MafG using chromatin immunoprecipitation and mutation analyses. We demonstrate that binding at this site acts to repress the induction of iNOS gene expression by cytokines. We show that this repressor is induced by TGF-beta1 and by Smad6-short, which enhances TGF-beta signaling. In contrast, the up-regulation of TCF11/MafG binding could be suppressed by overexpression of the TGF-beta inhibitor Smad7, and a small interfering RNA to TCF11 blocked the suppression of iNOS by TGF-beta. The binding of TCF11/MafG to the iNOS promoter could be enhanced by phorbol 12-myristate 13-acetate and suppressed by the protein kinase C inhibitor staurosporine. Moreover, the induction of TCF11/MafG binding by TGF-beta and Smad6-short could be blocked by staurosporine, and the effect of TGF-beta was blocked by the selective protein kinase C inhibitor calphostin C. Consistent with the in vitro data, we found suppression of TCF11 coincident with iNOS up-regulation in a rat model of endotoxemia, and we observed a highly significant negative correlation between TCF11 and nitric oxide production. Furthermore, treatment with activated protein C, a serine protease effective in septic shock, blocked the down-regulation of TCF11 and suppressed endotoxin-induced iNOS. Overall, our results demonstrate a novel mechanism by which iNOS expression is regulated in the context of inflammatory activation.Inducible nitric-oxide synthase (iNOS) plays a central role in the regulation of vascular function and response to injury. A central mediator controlling iNOS expression is transforming growth factor-beta (TGF-beta), which represses its expression through a mechanism that is poorly understood. We have identified a binding site in the iNOS promoter that interacts with the nuclear heterodimer TCF11/MafG using chromatin immunoprecipitation and mutation analyses. We demonstrate that binding at this site acts to repress the induction of iNOS gene expression by cytokines. We show that this repressor is induced by TGF-beta1 and by Smad6-short, which enhances TGF-beta signaling. In contrast, the up-regulation of TCF11/MafG binding could be suppressed by overexpression of the TGF-beta inhibitor Smad7, and a small interfering RNA to TCF11 blocked the suppression of iNOS by TGF-beta. The binding of TCF11/MafG to the iNOS promoter could be enhanced by phorbol 12-myristate 13-acetate and suppressed by the protein kinase C inhibitor staurosporine. Moreover, the induction of TCF11/MafG binding by TGF-beta and Smad6-short could be blocked by staurosporine, and the effect of TGF-beta was blocked by the selective protein kinase C inhibitor calphostin C. Consistent with the in vitro data, we found suppression of TCF11 coincident with iNOS up-regulation in a rat model of endotoxemia, and we observed a highly significant negative correlation between TCF11 and nitric oxide production. Furthermore, treatment with activated protein C, a serine protease effective in septic shock, blocked the down-regulation of TCF11 and suppressed endotoxin-induced iNOS. Overall, our results demonstrate a novel mechanism by which iNOS expression is regulated in the context of inflammatory activation. |
| Author | O'Brien, Lee A Calnek, David Grinnell, Brian W Berg, David T Richardson, Mark A Gupta, Akanksha |
| Author_xml | – sequence: 1 givenname: David T surname: Berg fullname: Berg, David T organization: Division of Biotechnology Discovery Research, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana 46285-0444, USA – sequence: 2 givenname: Akanksha surname: Gupta fullname: Gupta, Akanksha – sequence: 3 givenname: Mark A surname: Richardson fullname: Richardson, Mark A – sequence: 4 givenname: Lee A surname: O'Brien fullname: O'Brien, Lee A – sequence: 5 givenname: David surname: Calnek fullname: Calnek, David – sequence: 6 givenname: Brian W surname: Grinnell fullname: Grinnell, Brian W |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17928287$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkMtOwzAQRb0ooqWwZYm8YpdiO05TL1HFSyqwKevKscepq8QOtsPjg_hP-kJiNjManTtXc8_QwHkHCF1SMqGk5DebSk2eSzIVRDBCBmhECKOZYMVsiM5i3JBtcUFP0ZCWgs3YrByhnxeoZbIfgAPUfbMdvcPeYOt0r2zVAHY2Basy_2U14Pjt0lpGwPDVBYhxR7egrUygcVoH39drnIJ00fjQWlfjOvjPtMZGquRDVkGSmYYOnAaXcOv1P8-9TgXb7RcHBV7O7yk9RydGNhEujn2M3u7vlvPHbPH68DS_XWSKc54ySZkpBOSGFoXSU1YJoZkRXPF8pmllSKmLiipR5JwTQZjKDStVCVIoyaeasjG6Ptztgn_vIaZVa6OCppEOfB9X22jLnOU78OoI9tX2_1UXbCvD9-ovWPYLAXt_sQ |
| CitedBy_id | crossref_primary_10_3389_fcimb_2019_00071 crossref_primary_10_3382_ps_pew052 crossref_primary_10_1042_BJ20151182 crossref_primary_10_1007_s11259_010_9436_8 crossref_primary_10_1016_j_taap_2009_07_034 crossref_primary_10_1038_s41419_022_05080_5 crossref_primary_10_1016_j_freeradbiomed_2018_01_022 crossref_primary_10_1089_ars_2010_3590 crossref_primary_10_1016_j_bbadis_2020_165850 crossref_primary_10_1002_hep_23156 crossref_primary_10_1586_14789450_2013_841548 crossref_primary_10_1007_s11481_024_10136_8 crossref_primary_10_1016_j_freeradbiomed_2019_02_008 crossref_primary_10_1111_febs_12774 crossref_primary_10_1128_iai_00323_22 crossref_primary_10_1371_journal_pone_0148029 crossref_primary_10_1002_jcp_28930 crossref_primary_10_1371_journal_pone_0076979 crossref_primary_10_3390_ijms20071751 crossref_primary_10_1371_journal_pntd_0000582 crossref_primary_10_1093_cvr_cvn326 crossref_primary_10_1016_j_gene_2016_03_002 crossref_primary_10_1111_febs_12350 crossref_primary_10_3390_ijms21062014 crossref_primary_10_1016_j_apgeochem_2022_105267 crossref_primary_10_3390_antiox13070758 crossref_primary_10_1038_nrrheum_2014_137 crossref_primary_10_1016_j_canlet_2024_216931 crossref_primary_10_1038_s41392_022_01259_6 crossref_primary_10_3389_fonc_2021_707032 crossref_primary_10_1371_journal_pone_0048404 crossref_primary_10_1371_journal_pone_0161306 crossref_primary_10_1016_j_molcel_2010_09_012 crossref_primary_10_1016_j_semcdb_2017_09_019 crossref_primary_10_1038_npp_2014_137 crossref_primary_10_1158_1078_0432_CCR_22_2791 crossref_primary_10_1016_j_niox_2010_04_007 crossref_primary_10_1002_cam4_7021 crossref_primary_10_1016_j_cellsig_2019_109522 crossref_primary_10_1016_j_ijpharm_2015_08_090 crossref_primary_10_1016_j_atherosclerosis_2009_05_022 crossref_primary_10_1016_j_bbagrm_2015_08_001 crossref_primary_10_3389_fmed_2023_1060758 crossref_primary_10_4049_jimmunol_1102606 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1074/jbc.M706909200 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Anatomy & Physiology Chemistry |
| ExternalDocumentID | 17928287 |
| Genre | Journal Article |
| GroupedDBID | --- -DZ -ET -~X .55 0R~ 186 18M 2WC 34G 39C 4.4 53G 5BI 5GY 5RE 5VS 79B 85S AAEDW AAFWJ AALRI AARDX AAXUO ABDNZ ABOCM ABPPZ ABRJW ACGFO ACNCT ADBBV ADIYS ADNWM ADVLN AENEX AEXQZ AFFNX AFOSN AFPKN AI. AITUG AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS BTFSW C1A CGR CJ0 CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF EJD F5P FDB FRP GROUPED_DOAJ GX1 H13 HH5 HYE IH2 KQ8 L7B MVM N9A NPM OHT OK1 P-O P0W P2P PKN R.V RHF RHI RNS ROL RPM SJN TBC TN5 TR2 UHB UKR UPT UQL VH1 VQA W8F WH7 WHG WOQ X7M XSW Y6R YQT YSK YWH YZZ Z5M ZE2 ~02 ~KM .7T 7X8 AAYWO ABUFD ACVFH ADCNI ADXHL AEUPX AFPUW AIGII AKBMS AKYEP |
| ID | FETCH-LOGICAL-c444t-a12f59e3f155cd62b99d2f94c438d1bf07d5b1c953440902c3f27c7ea9ca46d12 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 56 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000251646000008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0021-9258 |
| IngestDate | Sun Nov 09 13:51:20 EST 2025 Wed Feb 19 02:29:14 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 51 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c444t-a12f59e3f155cd62b99d2f94c438d1bf07d5b1c953440902c3f27c7ea9ca46d12 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://dx.doi.org/10.1074/jbc.M706909200 |
| PMID | 17928287 |
| PQID | 69073231 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_69073231 pubmed_primary_17928287 |
| PublicationCentury | 2000 |
| PublicationDate | 2007-12-21 |
| PublicationDateYYYYMMDD | 2007-12-21 |
| PublicationDate_xml | – month: 12 year: 2007 text: 2007-12-21 day: 21 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | The Journal of biological chemistry |
| PublicationTitleAlternate | J Biol Chem |
| PublicationYear | 2007 |
| SSID | ssj0000491 |
| Score | 2.1420224 |
| Snippet | Inducible nitric-oxide synthase (iNOS) plays a central role in the regulation of vascular function and response to injury. A central mediator controlling iNOS... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 36837 |
| SubjectTerms | Animals Carcinogens - pharmacology Cells, Cultured Dimerization Disease Models, Animal Endotoxemia - enzymology Endotoxemia - genetics Enzyme Inhibitors - pharmacology Gene Expression Regulation, Enzymologic - drug effects Gene Expression Regulation, Enzymologic - genetics Hepatocyte Nuclear Factor 1-beta - antagonists & inhibitors Hepatocyte Nuclear Factor 1-beta - genetics Hepatocyte Nuclear Factor 1-beta - metabolism Humans Inflammation - enzymology Inflammation - genetics MafG Transcription Factor - genetics MafG Transcription Factor - metabolism Male Mutation Naphthalenes - pharmacology Nitric Oxide Synthase Type II - biosynthesis Nitric Oxide Synthase Type II - genetics Protein Kinase C - antagonists & inhibitors Rats Rats, Sprague-Dawley Repressor Proteins - genetics Repressor Proteins - metabolism Response Elements - genetics RNA, Small Interfering - genetics RNA, Small Interfering - pharmacology Signal Transduction - drug effects Signal Transduction - genetics Smad6 Protein - genetics Smad6 Protein - metabolism Smad7 Protein - genetics Smad7 Protein - metabolism Staurosporine - pharmacology Tetradecanoylphorbol Acetate - pharmacology Transforming Growth Factor beta1 - metabolism Transforming Growth Factor beta1 - pharmacology |
| Title | Negative regulation of inducible nitric-oxide synthase expression mediated through transforming growth factor-beta-dependent modulation of transcription factor TCF11 |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/17928287 https://www.proquest.com/docview/69073231 |
| Volume | 282 |
| WOSCitedRecordID | wos000251646000008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NT9wwELUoIJVLS6FQ2tLOAfXmYjvOOpYqVWjFigsrDlTa2yr-gq1KAmyo4Af1fzJ2YsGl6qGXnDJKlJm8eWOP5xFyUNZ2xCrLaDDMUcmZoabSngbla-TjZdAsJLEJNZ1Ws5k-WyHf8lmY2FaZMTEBtWttXCM_jFVcgWTk-_UNjZpRcW91ENB4QdYKJDIxptXsaVY4ct9eLy82IYiyyiMblTz8aezXUxWH9GrB2N_JZUoyk9f_93qb5NVALuGoj4Y3ZMU3W2T7qMHC-uoBvkBq90zr6Fvk5ThLvW2TP1N_kQaAw20vTY_OgjYA1ut3dmF-ecAfHwGTtvcL52H50HSXmP3A3w9ttA2kEyjIXmEQ_oEuM2LMjXCBxX53Cb24DzW-q2lW3-3gqnXPnpnsMpQNFnA-nnD-lvyYHJ-PT-ig30CtlLKjNReh1L4IyFmsGwmjtRNBSyuLynETmHKl4VaXhZSxPdQWQSiLQaJtLUeOix2y2rSNf0dAOTSVRsnA8WYptakRi-KWJ1eVMWyPfM5umeO3i5sedePbu-U8O2aP7PaenV_3YzzmCEWx3lTv_2n7gWykJV0uqOAfyVpAZPD7ZN3-7hbL208p7PA6PTt9BCRZ5zA |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Negative+regulation+of+inducible+nitric-oxide+synthase+expression+mediated+through+transforming+growth+factor-beta-dependent+modulation+of+transcription+factor+TCF11&rft.jtitle=The+Journal+of+biological+chemistry&rft.au=Berg%2C+David+T&rft.au=Gupta%2C+Akanksha&rft.au=Richardson%2C+Mark+A&rft.au=O%27Brien%2C+Lee+A&rft.date=2007-12-21&rft.issn=0021-9258&rft.volume=282&rft.issue=51&rft.spage=36837&rft_id=info:doi/10.1074%2Fjbc.M706909200&rft_id=info%3Apmid%2F17928287&rft_id=info%3Apmid%2F17928287&rft.externalDocID=17928287 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9258&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9258&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9258&client=summon |